Shantan Ravula, MD
Sleep Medicine · Chesterfield, VANPI 1245465541
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.0% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,223 and has fallen 67.2% since, to $402 in 2025.
Across 222 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$619
- Inspire Medical Systems, Inc.$461
- Pfizer$407
- Novo Nordisk$388
- AbbVie$248
- Boehringer Ingelheim$247
- plus $2K from 23 others
What the payments were for
- Food & beverage$3,69390%
- Education$41010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 19 | $619 |
| Inspire Medical Systems, Inc. | 8 | $461 |
| Pfizer | 28 | $407 |
| Novo Nordisk | 26 | $388 |
| AbbVie(2 entities) | 17 | $248 |
| Boehringer Ingelheim | 17 | $247 |
| Lilly USA, LLC | 14 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $186 |
| AstraZeneca | 12 | $179 |
| Harmony Biosciences LLC | 7 | $152 |
| Amgen | 9 | $137 |
| Amarin Pharma, Inc. | 9 | $136 |
| Johnson & Johnson | 8 | $110 |
| GSK | 7 | $101 |
| Abbott | 1 | $80 |
| Itamar Medical Inc | 1 | $63 |
| Merck | 5 | $63 |
| Sanofi-aventis U.S. LLC | 5 | $63 |
| Novartis | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Neos Therapeutics, LP | 2 | $29 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,103 in reported general payments places this provider in the 80th percentile of 74 sleep medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 12 | $655 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 14 | $158 |
| Ropinirole Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Chesterfield
- William WinterCharlottesville$1.1M
- Michael PolskyNorth Chesterfield$99K
- Astaad DalalFalls Church$99K
- Douglas PuryearMidlothian$49K
- Marc RaphaelsonLeesburg$47K
- Shahriar ShahzeidiLeesburg$27K
- Pascal NgongmonWoodbridge$25K
- Amit PatelFalls Church$14K
- Richard ParisiWilliamsburg$8K
- Vandana DhawanChesapeake$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.